Page last updated: 2024-10-22

2-amino-4-phosphonobutyric acid and Cancer of Colon

2-amino-4-phosphonobutyric acid has been researched along with Cancer of Colon in 1 studies

2-amino-4-phosphonobutyric acid: glutamate antagonist in locust muscle; structure; do not confuse with L-AP4, which is the propionic acid version

Research Excerpts

ExcerptRelevanceReference
"5-Fluorouracil (5-FU) has been the mainstay treatment for colorectal cancer for the past few decades."1.32Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line. ( Chang, HJ; Hong, SH; Jeon, E; Park, JG; Shin, YK; Yoo, BC, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoo, BC1
Jeon, E1
Hong, SH1
Shin, YK1
Chang, HJ1
Park, JG1

Other Studies

1 other study available for 2-amino-4-phosphonobutyric acid and Cancer of Colon

ArticleYear
Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jun-15, Volume: 10, Issue:12 Pt 1

    Topics: Amino Acids; Aminobutyrates; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blotting, Weste

2004